Europe Masitinib Market Report 2016

December 2016 | 106 pages | ID: E4A63C64154EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Masitinib

Revenue, means the sales value of Masitinib

This report studies sales (consumption) of Masitinib in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Bristol-Myers Squibb
• Eli Lilly and Company
• Merck & Co.
• Roche
• Taiho Pharmaceutical
• Sumitomo Dainippon Pharma

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Masitinib in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Masitinib in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Europe Masitinib Market Report 2016

1 MASITINIB OVERVIEW

1.1 Product Overview and Scope of Masitinib
1.2 Classification of Masitinib
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Masitinib
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Masitinib Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Masitinib (2011-2021)
  1.5.1 Europe Masitinib Sales and Growth Rate (2011-2021)
  1.5.2 Europe Masitinib Revenue and Growth Rate (2011-2021)

2 EUROPE MASITINIB BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Masitinib Market Competition by Manufacturers
  2.1.1 Europe Masitinib Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Masitinib Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Masitinib (Volume and Value) by Type
  2.2.1 Europe Masitinib Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Masitinib Revenue and Market Share by Type (2011-2016)
2.3 Europe Masitinib (Volume and Value) by Countries
  2.3.1 Europe Masitinib Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Masitinib Revenue and Market Share by Countries (2011-2016)
2.4 Europe Masitinib (Volume) by Application

3 GERMANY MASITINIB (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Masitinib Sales and Value (2011-2016)
  3.1.1 Germany Masitinib Sales and Growth Rate (2011-2016)
  3.1.2 Germany Masitinib Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Masitinib Sales Price Trend (2011-2016)
3.2 Germany Masitinib Sales and Market Share by Manufacturers
3.3 Germany Masitinib Sales and Market Share by Type
3.4 Germany Masitinib Sales and Market Share by Application

4 FRANCE MASITINIB (VOLUME, VALUE AND SALES PRICE)

4.1 France Masitinib Sales and Value (2011-2016)
  4.1.1 France Masitinib Sales and Growth Rate (2011-2016)
  4.1.2 France Masitinib Revenue and Growth Rate (2011-2016)
  4.1.4 France Masitinib Sales Price Trend (2011-2016)
4.2 France Masitinib Sales and Market Share by Manufacturers
4.3 France Masitinib Sales and Market Share by Type
4.4 France Masitinib Sales and Market Share by Application

5 UK MASITINIB (VOLUME, VALUE AND SALES PRICE)

5.1 UK Masitinib Sales and Value (2011-2016)
  5.1.1 UK Masitinib Sales and Growth Rate (2011-2016)
  5.1.2 UK Masitinib Revenue and Growth Rate (2011-2016)
  5.1.5 UK Masitinib Sales Price Trend (2011-2016)
5.2 UK Masitinib Sales and Market Share by Manufacturers
5.3 UK Masitinib Sales and Market Share by Type
5.4 UK Masitinib Sales and Market Share by Application

6 RUSSIA MASITINIB (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Masitinib Sales and Value (2011-2016)
  6.1.1 Russia Masitinib Sales and Growth Rate (2011-2016)
  6.1.2 Russia Masitinib Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Masitinib Sales Price Trend (2011-2016)
6.2 Russia Masitinib Sales and Market Share by Manufacturers
6.3 Russia Masitinib Sales and Market Share by Type
6.4 Russia Masitinib Sales and Market Share by Application

7 ITALY MASITINIB (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Masitinib Sales and Value (2011-2016)
  7.1.1 Italy Masitinib Sales and Growth Rate (2011-2016)
  7.1.2 Italy Masitinib Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Masitinib Sales Price Trend (2011-2016)
7.2 Italy Masitinib Sales and Market Share by Manufacturers
7.3 Italy Masitinib Sales and Market Share by Type
7.4 Italy Masitinib Sales and Market Share by Application

8 SPAIN MASITINIB (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Masitinib Sales and Value (2011-2016)
  8.1.1 Spain Masitinib Sales and Growth Rate (2011-2016)
  8.1.2 Spain Masitinib Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Masitinib Sales Price Trend (2011-2016)
8.2 Spain Masitinib Sales and Market Share by Manufacturers
8.3 Spain Masitinib Sales and Market Share by Type
8.4 Spain Masitinib Sales and Market Share by Application

9 BENELUX MASITINIB (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Masitinib Sales and Value (2011-2016)
  9.1.1 Benelux Masitinib Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Masitinib Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Masitinib Sales Price Trend (2011-2016)
9.2 Benelux Masitinib Sales and Market Share by Manufacturers
9.3 Benelux Masitinib Sales and Market Share by Type
9.4 Benelux Masitinib Sales and Market Share by Application

10 EUROPE MASITINIB MANUFACTURERS ANALYSIS

10.1 Bristol-Myers Squibb
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Masitinib Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Bristol-Myers Squibb Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Eli Lilly and Company
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Masitinib Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Eli Lilly and Company Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Merck & Co.
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Masitinib Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Merck & Co. Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Roche
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Masitinib Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Roche Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Taiho Pharmaceutical
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Masitinib Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Taiho Pharmaceutical Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Sumitomo Dainippon Pharma
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Masitinib Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Sumitomo Dainippon Pharma Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview

11 MASITINIB MANUFACTURING COST ANALYSIS

11.1 Masitinib Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Masitinib

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Masitinib Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Masitinib Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE MASITINIB MARKET FORECAST (2016-2021)

14.1 Germany Masitinib Sales Forecast (2016-2021)
14.2 France Masitinib Sales Forecast (2016-2021)
14.3 UK Masitinib Sales Forecast (2016-2021)
14.4 Russia Masitinib Sales Forecast (2016-2021)
14.5 Italy Masitinib Sales Forecast (2016-2021)
14.6 Spain Masitinib Sales Forecast (2016-2021)
14.7 Benelux Masitinib Sales Forecast (2016-2021)
14.8 Europe Masitinib Sales Forecast by Type (2016-2021)
14.9 Europe Masitinib Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Masitinib
Table Classification of Masitinib
Figure Europe Sales Market Share of Masitinib by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Masitinib
Figure Europe Sales Market Share of Masitinib by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Masitinib Revenue and Growth Rate (2011-2021)
Figure France Masitinib Revenue and Growth Rate (2011-2021)
Figure UK Masitinib Revenue and Growth Rate (2011-2021)
Figure Russia Masitinib Revenue and Growth Rate (2011-2021)
Figure Italy Masitinib Revenue and Growth Rate (2011-2021)
Figure Spain Masitinib Revenue and Growth Rate (2011-2021)
Figure Benelux Masitinib Revenue and Growth Rate (2011-2021)
Figure Europe Masitinib Sales and Growth Rate (2011-2021)
Figure Europe Masitinib Revenue and Growth Rate (2011-2021)
Table Europe Masitinib Sales of Key Manufacturers (2015 and 2016)
Table Europe Masitinib Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Masitinib Sales Share by Manufacturers
Figure 2016 Masitinib Sales Share by Manufacturers
Table Europe Masitinib Revenue by Manufacturers (2015 and 2016)
Table Europe Masitinib Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Masitinib Revenue Share by Manufacturers
Table 2016 Europe Masitinib Revenue Share by Manufacturers
Table Europe Masitinib Sales and Market Share by Type (2011-2016)
Table Europe Masitinib Sales Share by Type (2011-2016)
Figure Sales Market Share of Masitinib by Type (2011-2016)
Figure Europe Masitinib Sales Growth Rate by Type (2011-2016)
Table Europe Masitinib Revenue and Market Share by Type (2011-2016)
Table Europe Masitinib Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Masitinib by Type (2011-2016)
Figure Europe Masitinib Revenue Growth Rate by Type (2011-2016)
Table Europe Masitinib Sales and Market Share by Countries (2011-2016)
Table Europe Masitinib Sales Share by Countries (2011-2016)
Figure Sales Market Share of Masitinib by Countries (2011-2016)
Table Europe Masitinib Revenue and Market Share by Countries (2011-2016)
Table Europe Masitinib Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Masitinib by Countries (2011-2016)
Table Europe Masitinib Sales and Market Share by Application (2011-2016)
Table Europe Masitinib Sales Share by Application (2011-2016)
Figure Sales Market Share of Masitinib by Application (2011-2016)
Figure Germany Masitinib Sales and Growth Rate (2011-2016)
Figure Germany Masitinib Revenue and Growth Rate (2011-2016)
Figure Germany Masitinib Sales Price Trend (2011-2016)
Table Germany Masitinib Sales by Manufacturers (2015 and 2016)
Table Germany Masitinib Market Share by Manufacturers (2015 and 2016)
Table Germany Masitinib Sales by Type (2015 and 2016)
Table Germany Masitinib Market Share by Type (2015 and 2016)
Table Germany Masitinib Sales by Application (2015 and 2016)
Table Germany Masitinib Market Share by Application (2015 and 2016)
Figure France Masitinib Sales and Growth Rate (2011-2016)
Figure France Masitinib Revenue and Growth Rate (2011-2016)
Figure France Masitinib Sales Price Trend (2011-2016)
Table France Masitinib Sales by Manufacturers (2015 and 2016)
Table France Masitinib Market Share by Manufacturers (2015 and 2016)
Table France Masitinib Sales by Type (2015 and 2016)
Table France Masitinib Market Share by Type (2015 and 2016)
Table France Masitinib Sales by Application (2015 and 2016)
Table France Masitinib Market Share by Application (2015 and 2016)
Figure UK Masitinib Sales and Growth Rate (2011-2016)
Figure UK Masitinib Revenue and Growth Rate (2011-2016)
Figure UK Masitinib Sales Price Trend (2011-2016)
Table UK Masitinib Sales by Manufacturers (2015 and 2016)
Table UK Masitinib Market Share by Manufacturers (2015 and 2016)
Table UK Masitinib Sales by Type (2015 and 2016)
Table UK Masitinib Market Share by Type (2015 and 2016)
Table UK Masitinib Sales by Application (2015 and 2016)
Table UK Masitinib Market Share by Application (2015 and 2016)
Figure Russia Masitinib Sales and Growth Rate (2011-2016)
Figure Russia Masitinib Revenue and Growth Rate (2011-2016)
Figure Russia Masitinib Sales Price Trend (2011-2016)
Table Russia Masitinib Sales by Manufacturers (2015 and 2016)
Table Russia Masitinib Market Share by Manufacturers (2015 and 2016)
Table Russia Masitinib Sales by Type (2015 and 2016)
Table Russia Masitinib Market Share by Type (2015 and 2016)
Table Russia Masitinib Sales by Application (2015 and 2016)
Table Russia Masitinib Market Share by Application (2015 and 2016)
Figure Italy Masitinib Sales and Growth Rate (2011-2016)
Figure Italy Masitinib Revenue and Growth Rate (2011-2016)
Figure Italy Masitinib Sales Price Trend (2011-2016)
Table Italy Masitinib Sales by Manufacturers (2015 and 2016)
Table Italy Masitinib Market Share by Manufacturers (2015 and 2016)
Table Italy Masitinib Sales by Type (2015 and 2016)
Table Italy Masitinib Market Share by Type (2015 and 2016)
Table Italy Masitinib Sales by Application (2015 and 2016)
Table Italy Masitinib Market Share by Application (2015 and 2016)
Figure Spain Masitinib Sales and Growth Rate (2011-2016)
Figure Spain Masitinib Revenue and Growth Rate (2011-2016)
Figure Spain Masitinib Sales Price Trend (2011-2016)
Table Spain Masitinib Sales by Manufacturers (2015 and 2016)
Table Spain Masitinib Market Share by Manufacturers (2015 and 2016)
Table Spain Masitinib Sales by Type (2015 and 2016)
Table Spain Masitinib Market Share by Type (2015 and 2016)
Table Spain Masitinib Sales by Application (2015 and 2016)
Table Spain Masitinib Market Share by Application (2015 and 2016)
Figure Benelux Masitinib Sales and Growth Rate (2011-2016)
Figure Benelux Masitinib Revenue and Growth Rate (2011-2016)
Figure Benelux Masitinib Sales Price Trend (2011-2016)
Table Benelux Masitinib Sales by Manufacturers (2015 and 2016)
Table Benelux Masitinib Market Share by Manufacturers (2015 and 2016)
Table Benelux Masitinib Sales by Type (2015 and 2016)
Table Benelux Masitinib Market Share by Type (2015 and 2016)
Table Benelux Masitinib Sales by Application (2015 and 2016)
Table Benelux Masitinib Market Share by Application (2015 and 2016)
Table Masitinib Basic Information List
Table Bristol-Myers Squibb Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Masitinib Sales Market Share (2011-2016)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company Masitinib Sales Market Share (2011-2016)
Table Merck & Co. Basic Information List
Table Merck & Co. Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Masitinib Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Masitinib Sales Market Share (2011-2016)
Table Taiho Pharmaceutical Basic Information List
Table Taiho Pharmaceutical Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Taiho Pharmaceutical Masitinib Sales Market Share (2011-2016)
Table Sumitomo Dainippon Pharma Basic Information List
Table Sumitomo Dainippon Pharma Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sumitomo Dainippon Pharma Masitinib Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Masitinib
Figure Manufacturing Process Analysis of Masitinib
Figure Masitinib Industrial Chain Analysis
Table Raw Materials Sources of Masitinib Major Manufacturers in 2015
Table Major Buyers of Masitinib
Table Distributors/Traders List
Figure Germany Masitinib Sales and Growth Rate Forecast (2016-2021)
Figure Germany Masitinib Revenue and Growth Rate Forecast (2016-2021)
Figure France Masitinib Sales and Growth Rate Forecast (2016-2021)
Figure France Masitinib Revenue and Growth Rate Forecast (2016-2021)
Figure UK Masitinib Sales and Growth Rate Forecast (2016-2021)
Figure UK Masitinib Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Masitinib Sales and Growth Rate Forecast (2016-2021)
Figure Russia Masitinib Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Masitinib Sales and Growth Rate Forecast (2016-2021)
Figure Italy Masitinib Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Masitinib Sales and Growth Rate Forecast (2016-2021)
Figure Spain Masitinib Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Masitinib Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Masitinib Revenue and Growth Rate Forecast (2016-2021)
Table Europe Masitinib Sales Forecast by Type (2016-2021)
Table Europe Masitinib Sales Forecast by Application (2016-2021)